April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Induction Of Ocular Tissues From Human-induced Pluripotent Stem Cells On The Amniotic Membrane Matrix
Author Affiliations & Notes
  • Morio Ueno
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Organogenesis and Neurogenesis Group, RIKEN Center for Developmental Biology, Kobe, Japan
  • Yoshinori Nakai
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Organogenesis and Neurogenesis Group, RIKEN Center for Developmental Biology, Kobe, Japan
  • Michiru Matsumura
    Organogenesis and Neurogenesis Group, RIKEN Center for Developmental Biology, Kobe, Japan
  • Yoshiki Sasai
    Organogenesis and Neurogenesis Group, RIKEN Center for Developmental Biology, Kobe, Japan
  • Shigeru Kinoshita
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Footnotes
    Commercial Relationships  Morio Ueno, None; Yoshinori Nakai, None; Michiru Matsumura, None; Yoshiki Sasai, None; Shigeru Kinoshita, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3419. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Morio Ueno, Yoshinori Nakai, Michiru Matsumura, Yoshiki Sasai, Shigeru Kinoshita; Induction Of Ocular Tissues From Human-induced Pluripotent Stem Cells On The Amniotic Membrane Matrix. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3419.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Induced pluripotent stem (iPS) cells are generated by reprogramming somatic cells, thereby avoiding immune rejection and ethical issues, and patient-tailored iPS cells should prove to be valuable for regeneration medicine. We previously established a differentiation technique of pluripotent stem cells using the matrix components of the human amniotic membrane (denuded hAM) which induces the neural conversion of pluripotent stem cells including embryonic stem (ES) cells and iPS cells (amniotic membrane matrix-based ES cell differentiation, or AMED). The purpose of this present study was to investigate whether human iPS cells differentiate to ocular tissues, including corneal epithelia, on denuded hAM.

Methods: : hAMs encasing the fetus within the human female uterus were obtained during Caesarean section after obtaining proper informed consent from both parents and in accordance with the tenets of the Declaration of Helsinki. To prepare the denuded hAM for culture, the matrix was carefully removed from its overlying epithelium, and then transferred to cell culture plates. Dissociated human iPS cells were then seeded onto the denuded hAM and cultured in KSR (Invitrogen Corp., Carlsbad, CA)-containing Glasgow-MEM (Invitrogen) medium at 37°C under 5% CO2 .

Results: : Dissociated human iPS cells formed large colonies and differentiated into neural precursors at high efficiency when cultured on the denuded hAM in serum-free medium containing a selective ROCK inhibitor (Y-27632). AMED-induced human iPS cells developed to retinal pigment epithelia and lentoid tissues. Furthermore, AMED-induced epithelial cells were found to be positive for cytokeratin12 and Pax6; consistent with the characteristic of corneal epithelia. The percentage of human iPS cell-derived cytokeratin12-positive colonies increased to become up to 25% of the total colonies on denuded hAM.

Conclusions: : AMED should provide a highly practical system for generating corneal epithelia from human iPS cells without immune rejection or ethical problems for clinical application.

Keywords: regeneration • cornea: epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×